Biological Computation: the Development of a Genomic Analysis

Total Page:16

File Type:pdf, Size:1020Kb

Biological Computation: the Development of a Genomic Analysis BIOLOGICAL COMPUTATION: THE DEVELOPMENT OF A GENOMIC ANALYSIS PIPELINE TO IDENTIFY CELLULAR GENES MODULATED BY THE TRANSCRIPTION / SPLICING FACTOR SRSF1 by Evan Clark A Thesis Submitted to the Faculty of The College of Engineering and Computer Science In Partial Fulfillment of the Requirements for the Degree of Master of Science Florida Atlantic University Boca Raton, FL May 2017 Copyright 2017 by Evan Clark ii BIOLOGICAL COMPUTATION: THE DEVELOPMENT OF A GENOMIC ANALYSIS PIPELINE TO IDENTIFY CELLULAR GENES MODULATED BY THE TRANSCRIPTION / SPLICING FACTOR SRSF1 INTRODUCTION .......................................................................................... 1 BACKGROUND ON RNA-SEQ .................................................................. 2 THE SRSF1 PROTEIN ................................................................................. 5 INSTALLATION & DEPLOYMENT OF COMPUTATIONAL CLUSTER RESOURCES FOR RNA-SEQ DATA. .................................. 9 DEVELOPMENT OF ANALYSIS PIPELINE ...................................... 11 RNA-SEQ ANALYSIS OF HEK293 CELLS TRANSFECTED WITH AN SRSF1 AND AN RRM12 OVER EXPRESSION VECTOR. ....................................................................................................... 20 Preprocessing of sequencing data ............................................................................................... 22 Alignment of Sequences to Reference Genome ...................................................................... 23 Differential Gene Expression Analysis ....................................................................................... 23 Histone genes are regulated by SRSF1 expression ............................................................... 32 iv Key cellular pathways are regulated by SRSF1 ..................................................................... 36 APPENDIX A1 ............................................................................................. 44 BIBLIOGRAPHY ......................................................................................... 65 iv ABSTRACT Author: Evan Clark Title: Biological Computation: the development of a genomic analysis pipeline to identify cellular genes modulated by the transcription / splicing factor srsf1 Institution: Florida Atlantic University Thesis Advisor: Dr. Waseem Asghar Degree: Master of Science Year: 2017 SRSF1 is a widely expressed mammalian protein with multiple functions in the regulation of gene expression through processes including transcription, mRNA splicing, and translation. Although much is known of SRSF1 role in alternative splicing of specific genes little is known about its functions as a transcription factor and its global effect on cellular gene expression. We utilized a RNA sequencing (RNA-Seq) approach to determine the impact of SRSF1 in on cellular gene expression and analyzed both the short term (12 hours) and long term (48 hours) effects of SRSF1 expression in a human cell line. Furthermore, we analyzed and compared the effect of the expression of a naturally occurring deletion mutant of SRSF1 (RRM12) to the full-length protein. Our analysis reveals that shortly after v SRSF1 is over-expressed the transcription of several histone coding genes is down- regulated, allowing for a more relaxed chromatin state and efficient transcription by RNA Polymerase II. This effect is reversed at 48 hours. At the same time key genes for the immune pathways are activated, more notably Tumor Necrosis Factor-Alpha (TNF-α), suggesting a role for SRSF1 in T cell functions. vi INTRODUCTION Beginning in the early 2000s, the advent of novel methods for sequencing DNA became in high demand. Several technologies attempted to revolutionize sequencing through methods that would be later described as next generation. The major technique developed during this time was sequencing via synthesis. This method works by taking ssDNA fragments, hybridizing them to a well, and progressively adding nucleotides to each base until a match occurs and a visual reporter is induced through laser based molecular excitement. The development of synthesis sequencing technology has led to several new experimental techniques that allow for the quantification of DNA and RNA. One of these techniques is RNA sequencing (RNA-Seq). This sequencing method utilizes RNA transcripts obtained from samples that are converted to cDNA libraries and then sequenced. The sequencing results contain millions of sequenced transcripts known also as sequence reads. Each read contains the identified nucleotide sequence and a corresponding base quality score assigned by the sequencing device. RNA-seq has begun to replace techniques such as microarray used to identify changes in gene expression. Compared to microarray, RNA-seq provides several advantages, i) genome-wide analysis of transcript abundance that is not 1 limited by probe quantity, ii) identification of novel transcript sequences, iii) quantification of alternative splicing events. BACKGROUND ON RNA-SEQ RNA is first extracted from cells using either an organic phenol extraction or solid-phase extraction (utilized in this project). Solid phase extraction differs from organic extraction in that the RNA molecules bind directly to fibers composed of silica within a membrane, and can be eluted out after all other contaminants are washed away. In order to perform RNA-Seq the sample must be DNAsed and cleared of the ribosomal RNA that could interfere with the sequencing process. The extracted mRNA is then reverse-transcribed into cDNA, which will be amplified and used in sequencing. In order for the cDNA to be sequenced libraries, composed of amplified cDNA sequences of a specific length with proprietary sequences inserted within the cDNA, are generated. Library generation includes two major processes, adapter insertion and sequence amplification. Adapters are unique sequences of DNA 2 Figure 1. Flowchart for the sample preparation protocol utilized in RNA-Seq. used to tether each DNA fragment to the sequencing lane. Depending on the sequencing platform usage of adapter sequences may differ, however, in this case we focus on the illumina sequencing platforms. Additionally, barcode reads are inserted as part of the adapter sequence to easily determine the sample origin of each DNA fragment. Multiple fragments from several experiments can be included in a sequencing run; this is known as multiplexing. The adapters are 3 then used to generate clusters of similar fragments within the sequencing lanes through a process known as bridge amplification. After clusters are generated the fragments are ready to be sequenced. Figure 2. Sequencing Pipeline – Here is described the normal approach in conducting sequencing using the Illumina sequencing platform. Specifically, on an illumina NextSeq 500 cDNA is fragmented into equal length sequence pairs containing proprietary adpaters that attach the read to the sequencing bed. The NextSeq 500 can record up to 800 million paired-end reads per run spread across 8 lanes. Reads are amplified using bridge-amplification which generates reverse reads. The reads are again amplified to form clusters, and bases are called by progressively adding nucleotides to their corresponding base pairs. The reads emit a color when excited by a laser at 500nm, which are then read by a detector that reports a nucleotide. Images obtained from https://www.illumina.com/documents/products/techspotlights/techspotlight_sequencing.pdf 4 The sequencing process might utilize either single-end or paired-end reads. Single-end reads are only read from a single direction during sequencing, whereas paired-end reads are read from both directions. Using paired-end sequencing improves overall sequencing quality, allows for the identification of sequence rearrangements, allows for better alignment of reads to a reference genome, and allows for the identification of novel isoforms by decreasing the number of sequence fragment gaps that occur during alignment. Using the illumina platform, sequencing is performed through a method known as sequencing via synthesis. During sequencing, special nucleotides containing a unique fluorescent reporter molecule are hybridized to their matching bases on each fragment. During this process, a laser at wavelength of 488nm excites the fluorescent tags and a detector reads the color response. These responses are then recorded as a base call for each fragment. This information is then written to a multiplexed bax file containing all the reads from each sequencing run. This file is then demultiplexed using the barcode sequences inserted earlier to produce FASTQ files for each sample. If a sample is split across multiple sequencing lanes, then a FATQ file for each lane is generated as well. THE SRSF1 PROTEIN The serine/arginine rich splicing factor 1 (SRSF1) is a widely expressed mammalian RNA binding protein that is a member of the serine-arginine rich protein family. SRSF1 contains three major domains within the structure (Fig. 3), RNA recognition Motif 1(RRM1) (16-91 aa), RNA recognition Motif 2 (RRM2) 5 (121-195 aa) and the serine arginine rich (SR) (198-247 aa) domain. RRM1 and RRM2 have a significant role in RNA binding while the SR domain is thought to mediate protein/protein interactions and it is heavily phosphorylated. SRSF1 has multiple functions in regulating gene expression through biological processes including transcription, mRNA splicing, and translation. Specifically, its primary function is to serve as a master regulator for alternative
Recommended publications
  • Environmental Influences on Endothelial Gene Expression
    ENDOTHELIAL CELL GENE EXPRESSION John Matthew Jeff Herbert Supervisors: Prof. Roy Bicknell and Dr. Victoria Heath PhD thesis University of Birmingham August 2012 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Tumour angiogenesis is a vital process in the pathology of tumour development and metastasis. Targeting markers of tumour endothelium provide a means of targeted destruction of a tumours oxygen and nutrient supply via destruction of tumour vasculature, which in turn ultimately leads to beneficial consequences to patients. Although current anti -angiogenic and vascular targeting strategies help patients, more potently in combination with chemo therapy, there is still a need for more tumour endothelial marker discoveries as current treatments have cardiovascular and other side effects. For the first time, the analyses of in-vivo biotinylation of an embryonic system is performed to obtain putative vascular targets. Also for the first time, deep sequencing is applied to freshly isolated tumour and normal endothelial cells from lung, colon and bladder tissues for the identification of pan-vascular-targets. Integration of the proteomic, deep sequencing, public cDNA libraries and microarrays, delivers 5,892 putative vascular targets to the science community.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplementary Information
    Supplementary Information This text file includes: Supplementary Methods Supplementary Figure 1-13, 15-30 Supplementary Table 1-8, 16, 20-21, 23, 25-37, 40-41 1 1. Samples, DNA extraction and genome sequencing 1.1 Ethical statements and sample storage The ethical statements of collecting and processing tissue samples for each species are listed as follows: Myotis myotis: All procedures were carried out in accordance with the ethical guidelines and permits (AREC-13-38-Teeling) delivered by the University College Dublin and the Préfet du Morbihan, awarded to Emma Teeling and Sébastien Puechmaille respectively. A single M. myotis individual was humanely sacrificed given that she had lethal injuries, and dissected. Rhinolophus ferrumequinum: All the procedures were conducted under the license (Natural England 2016-25216-SCI-SCI) issued to Gareth Jones. The individual bat died unexpectedly and suddenly during sampling and was dissected immediately. Pipistrellus kuhlii: The sampling procedure was carried out following all the applicable national guidelines for the care and use of animals. Sampling was done in accordance with all the relevant wildlife legislation and approved by the Ministry of Environment (Ministero della Tutela del Territorio e del Mare, Aut.Prot. N˚: 13040, 26/03/2014). Molossus molossus: All sampling methods were approved by the Ministerio de Ambiente de Panamá (SE/A-29-18) and by the Institutional Animal Care and Use Committee of the Smithsonian Tropical Research Institute (2017-0815-2020). Phyllostomus discolor: P. discolor bats originated from a breeding colony in the Department Biology II of the Ludwig-Maximilians-University in Munich. Approval to keep and breed the bats was issued by the Munich district veterinary office.
    [Show full text]
  • Anti- Histone-H3 Antibody
    anti- Histone-H3 antibody Product Information Catalog No.: FNab03890 Size: 100μg Form: liquid Purification: Immunogen affinity purified Purity: ≥95% as determined by SDS-PAGE Host: Rabbit Clonality: polyclonal Clone ID: None IsoType: IgG Storage: PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.) Background HIST2H3A,histone cluster 2, H3a.It is the core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. HIST2H3A is Expressed during S phase, then expression strongly decreases as cell division slows down during the process of differentiation. Immunogen information Immunogen: histone cluster 2, H3a Synonyms: H3/n, H3/o, H3F2, H3FM, HIST2H3A, HIST2H3C, HIST2H3D, histone cluster 2, H3a, Histone H3, Histone H3.2, Histone H3/m, Histone H3/o Observed MW: 15-17 kDa Uniprot ID : Q71DI3 Application 1 Wuhan Fine Biotech Co., Ltd. B9 Bld, High-Tech Medical Devices Park, No. 818 Gaoxin Ave.East Lake High-Tech Development Zone.Wuhan, Hubei, China(430206) Tel :( 0086)027-87384275 Fax: (0086)027-87800889 www.fn-test.com Reactivity: Human, Mouse, Rat Tested Application: ELISA, WB, IHC, IF Recommended dilution: WB: 1:500-1:5000; IHC: 1:50-1:200; IF: 1:20-1:200 Image: Immunohistochemistry of paraffin-embedded human breast cancer tissue slide using FNab03890(Histone-H3 Antibody) at dilution of 1:50 Immunofluorescent analysis of HEK-293 cells using FNab03890 (Histone-H3 Antibody) at dilution of 1:50 and Rhodamine-Goat anti-Rabbit IgG 2 Wuhan Fine Biotech Co., Ltd.
    [Show full text]
  • Histones: Controlling Tumor Signaling Circuitry Manoela D
    genesi ino s & rc a M C u t f a o g l Journal of Carcinogenesis & e a n n e Martins and Castilho, J Carcinogene Mutagene 2013, S5 r s u i s o DOI: 4172/2157-2518.S5-001 J Mutagenesis ISSN: 2157-2518 ReviewResearch Article Article OpenOpen Access Access Histones: Controlling Tumor Signaling Circuitry Manoela D. Martins1 and Rogerio M. Castilho2* 1Department of Oral Pathology, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil 2Laboratory of Epithelial Biology, Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, MI, USA Abstract Epigenetic modifications constitute the next frontier in tumor biology research. Post-translation modification of histones dynamically influences gene expression independent of alterations to the DNA sequence. These mechanisms are often mediated by histone linkers or by proteins associated with the recruitment of DNA-binding proteins, HDAC I and II interacting proteins and transcriptional activators, coactivators or corepressors. Early evidence suggested that histones and their modifiers are involved in sophisticated processes that modulate tumor behavior and cellular phenotype. In this review, we discuss how recent discoveries about chromatin modifications, particularly histone acetylation, are shaping our knowledge of cell biology and our understanding of the molecular circuitry governing tumor progression and consider whether recent insights may extend to novel therapeutic approaches. Furthermore, we discuss the latest oncogenomic findings in Head and Neck Squamous Cell Carcinoma (HNSCC) from studies using Next Generation Sequencing (NGS) technology and highlight the impact of mutations identified in histones and their modifiers. Keywords: H3; H4; Oral cancer; Whole genome sequencing, Genetic directly influence chromatin DNA packaging, resulting in a code; Histone modifications; Acetylation; Chromatin compaction decondensed structure and enhanced interactions with transcription factors.
    [Show full text]
  • HIST2H3C(27Ac) Antibody Purified Mouse Monoclonal Antibody Catalog # Ao2159a
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 HIST2H3C(27Ac) Antibody Purified Mouse Monoclonal Antibody Catalog # AO2159a Specification HIST2H3C(27Ac) Antibody - Product Information Application E, WB, FC, IHC Primary Accession Q71DI3 Reactivity Human Host Mouse Clonality Monoclonal Isotype IgG1 Calculated MW 15.4kDa KDa Description Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. This structure consists of approximately 146 bp of DNA wrapped around a nucleosome, an octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a member of the histone H3 family. Transcripts from this gene lack polyA tails; instead, they contain a palindromic termination element. This gene is found in a histone cluster on chromosome 1. This gene is one of four histone genes in the cluster that are duplicated; this record represents the telomeric copy. Immunogen Synthesized peptide of human HIST2H3C (AA: ATKAARK(Ac)SAPATGGV). Formulation Purified antibody in PBS with 0.05% sodium azide HIST2H3C(27Ac) Antibody - Additional Information Gene ID 126961;333932;653604 Dilution E~~1/10000 Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 WB~~1/500 - 1/2000 FC~~1/200 - 1/400 IHC~~1/200 - 1/1000 Storage Maintain refrigerated at 2-8°C for up to 6 months.
    [Show full text]
  • Protein Interactions in the Cancer Proteome† Cite This: Mol
    Molecular BioSystems View Article Online PAPER View Journal | View Issue Small-molecule binding sites to explore protein– protein interactions in the cancer proteome† Cite this: Mol. BioSyst., 2016, 12,3067 David Xu,ab Shadia I. Jalal,c George W. Sledge Jr.d and Samy O. Meroueh*aef The Cancer Genome Atlas (TCGA) offers an unprecedented opportunity to identify small-molecule binding sites on proteins with overexpressed mRNA levels that correlate with poor survival. Here, we analyze RNA-seq and clinical data for 10 tumor types to identify genes that are both overexpressed and correlate with patient survival. Protein products of these genes were scanned for binding sites that possess shape and physicochemical properties that can accommodate small-molecule probes or therapeutic agents (druggable). These binding sites were classified as enzyme active sites (ENZ), protein–protein interaction sites (PPI), or other sites whose function is unknown (OTH). Interestingly, the overwhelming majority of binding sites were classified as OTH. We find that ENZ, PPI, and OTH binding sites often occurred on the same structure suggesting that many of these OTH cavities can be used for allosteric modulation of Creative Commons Attribution 3.0 Unported Licence. enzyme activity or protein–protein interactions with small molecules. We discovered several ENZ (PYCR1, QPRT,andHSPA6)andPPI(CASC5, ZBTB32,andCSAD) binding sites on proteins that have been seldom explored in cancer. We also found proteins that have been extensively studied in cancer that have not been previously explored with small molecules that harbor ENZ (PKMYT1, STEAP3,andNNMT) and PPI (HNF4A, MEF2B,andCBX2) binding sites. All binding sites were classified by the signaling pathways to Received 29th March 2016, which the protein that harbors them belongs using KEGG.
    [Show full text]
  • Expression Analysis of Progesterone‑Regulated Mirnas in Cells Derived from Human Glioblastoma
    MOLECULAR MEDICINE REPORTS 23: 475, 2021 Expression analysis of progesterone‑regulated miRNAs in cells derived from human glioblastoma DIANA ELISA VELÁZQUEZ‑VÁZQUEZ1, AYLIN DEL MORAL‑MORALES1, JENIE MARIAN CRUZ‑BURGOS2, EDUARDO MARTÍNEZ‑MARTÍNEZ3, MAURICIO RODRÍGUEZ‑DORANTES2 and IGNACIO CAMACHO‑ARROYO1 1Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología‑Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510; 2Oncogenomics Laboratory, The National Institute of Genomic Medicine; 3Laboratory of Cell Communication and Extracellular Vesicles, The National Institute of Genomic Medicine, Mexico City 14610, Mexico Received August 16, 2020; Accepted February 2, 2021 DOI: 10.3892/mmr.2021.12114 Abstract. Glioblastomas (GBMs) are the most frequent and is characterized by being highly infiltrative, angiogenic and malignant type of brain tumor. It has been reported that resistant to chemotherapy and radiotherapy. The medical progesterone (P4) regulates the progression of GBMs by modi‑ history of patients with GBM is short as few of them survive fying the expression of genes that promote cell proliferation, more than one year (1‑3). GBM is mainly diagnosed in adults migration and invasion; however, it is not fully understood >50 years old, but it can occur at any age and the incidence is how these processes are regulated. It is possible that P4 medi‑ higher in men than in women (3:2) (4). ates some of these effects through changes in the microRNA Studies have focused on the identification of new biomarkers (miRNA) expression profile in GBM cells. The present study and therapeutic agents in GBM. Of particular interest are the investigated the effects of P4 on miRNAs expression profile microRNAs (miRNAs), which are single‑stranded, short, in U‑251MG cells derived from a human GBM.
    [Show full text]
  • Application of NGS Technology in Understanding the Pathology of Autoimmune Diseases
    Journal of Clinical Medicine Review Application of NGS Technology in Understanding the Pathology of Autoimmune Diseases Anna Wajda 1 , Larysa Sivitskaya 2,* and Agnieszka Paradowska-Gorycka 1 1 Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland; [email protected] (A.W.); [email protected] (A.P.-G.) 2 Institute of Genetics and Cytology, National Academy of Sciences of Belarus, 220072 Minsk, Belarus * Correspondence: [email protected] Abstract: NGS technologies have transformed clinical diagnostics and broadly used from neonatal emergencies to adult conditions where the diagnosis cannot be made based on clinical symptoms. Autoimmune diseases reveal complicate molecular background and traditional methods could not fully capture them. Certainly, NGS technologies meet the needs of modern exploratory research, diagnostic and pharmacotherapy. Therefore, the main purpose of this review was to briefly present the application of NGS technology used in recent years in the understanding of autoimmune diseases paying particular attention to autoimmune connective tissue diseases. The main issues are presented in four parts: (a) panels, whole-genome and -exome sequencing (WGS and WES) in diagnostic, (b) Human leukocyte antigens (HLA) as a diagnostic tool, (c) RNAseq, (d) microRNA and (f) microbiome. Although all these areas of research are extensive, it seems that epigenetic impact on the development of systemic autoimmune diseases will set trends for future studies on this area. Citation: Wajda, A.; Sivitskaya, L.; Keywords: next-generation sequencing; autoimmune diseases; autoimmune connective tissue dis- Paradowska-Gorycka, A. Application eases; HLA; microRNA; microbiome of NGS Technology in Understanding the Pathology of Autoimmune Diseases. J. Clin.
    [Show full text]
  • Histone-Related Genes Are Hypermethylated in Lung Cancer
    Published OnlineFirst October 1, 2019; DOI: 10.1158/0008-5472.CAN-19-1019 Cancer Genome and Epigenome Research Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker Shihua Dong1,Wei Li1, Lin Wang2, Jie Hu3,Yuanlin Song3, Baolong Zhang1, Xiaoguang Ren1, Shimeng Ji3, Jin Li1, Peng Xu1, Ying Liang1, Gang Chen4, Jia-Tao Lou2, and Wenqiang Yu1 Abstract Lung cancer is the leading cause of cancer-related deaths lated in all 17 tumor types from TCGA datasets (n ¼ 7,344), worldwide. Cytologic examination is the current "gold stan- which was further validated in nine different types of cancer dard" for lung cancer diagnosis, however, this has low sensi- (n ¼ 243). These results demonstrate that HIST1H4F can tivity. Here, we identified a typical methylation signature of function as a universal-cancer-only methylation (UCOM) histone genes in lung cancer by whole-genome DNA methyl- marker, which may aid in understanding general tumorigen- ation analysis, which was validated by The Cancer Genome esis and improve screening for early cancer diagnosis. Atlas (TCGA) lung cancer cohort (n ¼ 907) and was further confirmed in 265 bronchoalveolar lavage fluid samples with Significance: These findings identify a new biomarker for specificity and sensitivity of 96.7% and 87.0%, respectively. cancer detection and show that hypermethylation of histone- More importantly, HIST1H4F was universally hypermethy- related genes seems to persist across cancers. Introduction to its low specificity, LDCT is far from satisfactory as a screening tool for clinical application, similar to other currently used cancer Lung cancer is one of the most common malignant tumors and biomarkers, such as carcinoembryonic antigen (CEA), neuron- the leading cause of cancer-related deaths worldwide (1, 2).
    [Show full text]
  • Pentosan Polysulfate Binds to STRO
    Wu et al. Stem Cell Research & Therapy (2017) 8:278 DOI 10.1186/s13287-017-0723-y RESEARCH Open Access Pentosan polysulfate binds to STRO-1+ mesenchymal progenitor cells, is internalized, and modifies gene expression: a novel approach of pre-programing stem cells for therapeutic application requiring their chondrogenesis Jiehua Wu1,7, Susan Shimmon1,8, Sharon Paton2, Christopher Daly3,4,5, Tony Goldschlager3,4,5, Stan Gronthos6, Andrew C. W. Zannettino2 and Peter Ghosh1,5* Abstract Background: The pharmaceutical agent pentosan polysulfate (PPS) is known to induce proliferation and chondrogenesis of mesenchymal progenitor cells (MPCs) in vitro and in vivo. However, the mechanism(s) of action of PPS in mediating these effects remains unresolved. In the present report we address this issue by investigating the binding and uptake of PPS by MPCs and monitoring gene expression and proteoglycan biosynthesis before and after the cells had been exposed to limited concentrations of PPS and then re-established in culture in the absence of the drug (MPC priming). Methods: Immuno-selected STRO-1+ mesenchymal progenitor stem cells (MPCs) were prepared from human bone marrow aspirates and established in culture. The kinetics of uptake, shedding, and internalization of PPS by MPCs was determined by monitoring the concentration-dependent loss of PPS media concentrations using an enzyme-linked immunosorbent assay (ELISA) and the uptake of fluorescein isothiocyanate (FITC)-labelled PPS by MPCs. The proliferation of MPCs, following pre-incubation and removal of PPS (priming), was assessed using the Wst-8 assay 35 method, and proteoglycan synthesis was determined by the incorporation of SO4 into their sulphated glycosaminoglycans.
    [Show full text]
  • A Yeast Phenomic Model for the Influence of Warburg Metabolism on Genetic Buffering of Doxorubicin Sean M
    Santos and Hartman Cancer & Metabolism (2019) 7:9 https://doi.org/10.1186/s40170-019-0201-3 RESEARCH Open Access A yeast phenomic model for the influence of Warburg metabolism on genetic buffering of doxorubicin Sean M. Santos and John L. Hartman IV* Abstract Background: The influence of the Warburg phenomenon on chemotherapy response is unknown. Saccharomyces cerevisiae mimics the Warburg effect, repressing respiration in the presence of adequate glucose. Yeast phenomic experiments were conducted to assess potential influences of Warburg metabolism on gene-drug interaction underlying the cellular response to doxorubicin. Homologous genes from yeast phenomic and cancer pharmacogenomics data were analyzed to infer evolutionary conservation of gene-drug interaction and predict therapeutic relevance. Methods: Cell proliferation phenotypes (CPPs) of the yeast gene knockout/knockdown library were measured by quantitative high-throughput cell array phenotyping (Q-HTCP), treating with escalating doxorubicin concentrations under conditions of respiratory or glycolytic metabolism. Doxorubicin-gene interaction was quantified by departure of CPPs observed for the doxorubicin-treated mutant strain from that expected based on an interaction model. Recursive expectation-maximization clustering (REMc) and Gene Ontology (GO)-based analyses of interactions identified functional biological modules that differentially buffer or promote doxorubicin cytotoxicity with respect to Warburg metabolism. Yeast phenomic and cancer pharmacogenomics data were integrated to predict differential gene expression causally influencing doxorubicin anti-tumor efficacy. Results: Yeast compromised for genes functioning in chromatin organization, and several other cellular processes are more resistant to doxorubicin under glycolytic conditions. Thus, the Warburg transition appears to alleviate requirements for cellular functions that buffer doxorubicin cytotoxicity in a respiratory context.
    [Show full text]